Q1 2025 Holdings
Filed 2025-05-15 | 49 holdings | $97.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $15.4M | 6,986,744 | 15.8% |
| Acelyrin Inc | COM | 00445A100 | $8.3M | 3,366,945 | 8.6% |
| Springworks Therapeutics Inc | COM | 85205L107 | $8.2M | 185,520 | 8.4% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $7.1M | 1,667,800 | 7.3% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $7.0M | 185,000 | 7.2% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $6.9M | 455,412 | 7.1% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $6.2M | 1,433,828 | 6.3% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $6.0M | 95,000 | 6.2% |
| Zevra Therapeutics Inc(ZVRA) | COM NEW | 488445206 | $5.0M | 665,000 | 5.1% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $4.4M | 300,000 | 4.6% |
| Inspiremd Inc(NSPR) | COM | 45779A846 | $2.4M | 904,029 | 2.5% |
| Scpharmaceuticals Inc(SCPH) | COM | 810648105 | $2.4M | 917,668 | 2.5% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $2.4M | 150,600 | 2.5% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $1.8M | 182,083 | 1.8% |
| Edesa Biotech Inc(EDSA) | COM NEW | 27966L306 | $1.7M | 687,500 | 1.7% |
| Instil BIO Inc(TIL) | COM NEW | 45783C200 | $1.2M | 69,000 | 1.2% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $1.2M | 400,000 | 1.2% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $1.1M | 323,973 | 1.1% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $1.1M | 500,000 | 1.1% |
| Geron Corp(GERN) | COM | 374163103 | $1.0M | 655,000 | 1.1% |
| Immunome Inc(IMNM) | COM | 45257U108 | $1.0M | 153,500 | 1.1% |
| Tela BIO Inc(TELA) | COM | 872381108 | $911.8K | 747,410 | 0.9% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $896.9K | 111,972 | 0.9% |
| Sutro Biopharma Inc | COM | 869367102 | $670.1K | 1,030,000 | 0.7% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $654.8K | 107,000 | 0.7% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $545.8K | 83,333 | 0.6% |
| Kiora Pharmaceuticals Inc(KPRX) | COM | 49721T507 | $367.9K | 122,223 | 0.4% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $313.3K | 59,000 | 0.3% |
| Regulus Therapeutics Inc(RGLS) | COM | 75915K309 | $140.0K | 80,000 | 0.1% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $105.0K | 13,000 | 0.1% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $82.5K | 75,000 | 0.1% |
| Erasca Inc(ERAS) | COM | 29479A108 | $68.5K | 50,000 | 0.1% |
| Alector Inc(ALEC) | COM | 014442107 | $67.7K | 55,000 | 0.1% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $60.2K | 28,000 | 0.1% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $59.9K | 45,000 | 0.1% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $55.1K | 90,000 | 0.1% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $54.0K | 14,000 | 0.1% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $53.6K | 35,000 | 0.1% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $47.7K | 75,000 | 0.0% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $46.9K | 17,000 | 0.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $46.0K | 40,000 | 0.0% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $38.8K | 12,000 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $38.2K | 35,000 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $30.3K | 97,000 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $28.9K | 35,000 | 0.0% |
| Nextcure Inc | COM | 65343E108 | $12.0K | 25,000 | 0.0% |
| Elevation Oncology Inc | COM | 28623U101 | $11.7K | 45,000 | 0.0% |